摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

5-(4-cyclopropylphenyl)-1-(2,4-dichlorophenyl)-4-methyl-N-cyclopropyl-1H-pyrazole-3-carboxamide | 1034891-46-7

中文名称
——
中文别名
——
英文名称
5-(4-cyclopropylphenyl)-1-(2,4-dichlorophenyl)-4-methyl-N-cyclopropyl-1H-pyrazole-3-carboxamide
英文别名
N-cyclopropyl-5-(4-cyclopropylphenyl)-1-(2,4-dichlorophenyl)-4-methylpyrazole-3-carboxamide
5-(4-cyclopropylphenyl)-1-(2,4-dichlorophenyl)-4-methyl-N-cyclopropyl-1H-pyrazole-3-carboxamide化学式
CAS
1034891-46-7
化学式
C23H21Cl2N3O
mdl
——
分子量
426.345
InChiKey
GSZYFYMIUWFNMQ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    6.2
  • 重原子数:
    29
  • 可旋转键数:
    5
  • 环数:
    5.0
  • sp3杂化的碳原子比例:
    0.3
  • 拓扑面积:
    46.9
  • 氢给体数:
    1
  • 氢受体数:
    2

文献信息

  • HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DIODE INCLUDING THE SAME
    申请人:SAMSUNG DISPLAY CO., LTD.
    公开号:US20140239260A1
    公开(公告)日:2014-08-28
    A heterocyclic compound is represented by Formula 1. The heterocyclic compound may be used in an organic layer of an organic light-emitting diode. An organic light-emitting diode includes a first electrode, a second electrode and an organic layer, and the organic layer includes the heterocyclic compound represented by Formula 1. The organic light-emitting diode may be used in a flat panel display device, in which the first electrode of the organic light-emitting diode may be electrically connected to a source or drain electrode of a thin film transistor.
  • [EN] NOVEL CB1 ANTAGONISTS AND THEIR PREPARATION<br/>[FR] NOUVEAUX ANTAGONISTES DE LA CB1, ET LEUR PRÉPARATION
    申请人:RICHTER GEDEON NYRT
    公开号:WO2008075118A1
    公开(公告)日:2008-06-26
    [EN] The invention relates to new compounds of general formula (I) acting as CB1 antagonists and to their preparation. The compounds according to this invention can be used for the treatment of obesity, behavioral addictions, psychiatric and metabolic disorders.
    [FR] L'invention porte sur de nouveaux composés de formule générale (I), antagonistes de la CB1, et sur leur préparation. Lesdits composés peuvent s'utiliser pour le traitement de l'obésité, de la toxicomanie, et de troubles psychiatriques et métaboliques.
查看更多